EX-FILING FEES
Published on March 3, 2022
Exhibit 107
Calculation of Filing Fee Tables
F-10
(Form Type)
Profound Medical
Corp.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type | Security Class Title |
Fee Calculation or Carry Forward Rule |
Amount Registered |
Proposed Maximum Offering Price Per Unit |
Maximum Aggregate Offering Price |
Fee Rate | Amount of Registration Fee |
|||||||||
| Fees to be Paid | Equity | Common Shares | 457(o) | (1) | (1) | (1)(2) | 0.0000927 | (1) | ||||||||
| Fees to be Paid | Other | Warrants | 457(o) | (1) | (1) | (1)(2) | 0.0000927 | (1) | ||||||||
| Fees to be Paid | Debt | Debt Securities | 457(o) | (1) | (1) | (1)(2) | 0.0000927 | (1) | ||||||||
| Fees to be Paid | Other | Subscription Receipts | 457(o) | (1) | (1) | (1)(2) | 0.0000927 | (1) | ||||||||
| Fees to be Paid | Other | Units | 457(o) | (1) | (1) | (1)(2) | 0.0000927 | (1) | ||||||||
| Total Offering Amounts | US$100,000,000 | 0.0000927 | US$9,270.00 | |||||||||||||
| Fees Previously Paid | (3) | (3) | ||||||||||||||
| Total Fee Offsets | US$1,510.92 (4) | |||||||||||||||
| Net Fee Due | US$7,759.08 | |||||||||||||||
| (1) | There are being registered under this Registration Statement such indeterminate number of Common Shares, Warrants, Debt Securities, Subscription Receipts and Units to be sold by Profound Medical Corp. (the “Registrant”) and Common Shares to be sold by the selling shareholders named in the prospectus (collectively, the “Selling Shareholders”) as shall have an aggregate initial offering price not to exceed US$100,000,000. The proposed maximum initial offering price per security will be determined, from time to time, by the Registrant and/or the Selling Shareholders in connection with the sale of the securities under this Registration Statement. |
| (2) | Separate consideration may not be received for registered securities that are issuable on exercise, conversion or exchange of other securities. |
| (3) | Not applicable. |
| (4) | A registration fee in the amount of $12,120.00 was previously paid by the Registrant, in connection with the filing of a Registration Statement on Form F-10 (Registration No. 333-233997). This F-10 Registration Statement was not fully used, resulting in $12,466,307.00 as the unsold aggregate offering amount. This unused amount represents 12.5% of the $12,120.00 paid on the previous F-10 and results in a fee offset of $1,510.92. Pursuant to Rule 457(p) under the Securities Act of 1933, the registrant hereby applies $1,510.92 of those unused registration fees to offset against the amounts due herewith. Accordingly, the registration fee owed in connection with this Registration Statement on Form F-10 is $7,759.09. |
1
Table 2: Fee Offset Claims and Sources
| Registrant or Filer Name |
Form
or Filing Type |
File Number |
Initial Filing Date |
Filing Date | Fee
Offset Claimed |
Security
Type Associated with Fee Offset Claimed |
Security
Title Associated with Fee Offset Claimed |
Unsold Securities Associated with Fee Offset Claimed |
Unsold
Aggregate Offering Amount Associated with Fee Offset Claimed |
Fee
Paid with Fee Offset Source |
|||||||||||||||||
| Rule 457(p) | |||||||||||||||||||||||||||
| Fee Offset Claims | Profound Medical Corp. | F-10 | 333-233997 | 2019-09-27 | $ | 1,510.92 | Equity/Debt/Other | (1) | (1) | $ | 12,466,307.00 | ||||||||||||||||
| Fee Offset Sources | Profound Medical Corp. | F-10 | 333-233997 | 2019-09-27 | $ | 12,120.00 | |||||||||||||||||||||
| (1) | This Registration Statement contained an indeterminate number of Common Shares, Warrants, Debt Securities, Subscription Receipts and Units to be sold by Profound Medical Corp. (the “Registrant”) and Common Shares to be sold by the selling shareholders named in the prospectus (collectively, the “Selling Shareholders”) and had an aggregate initial offering price not to exceed US$100,000,000. |
2